NCT07606820已完成不适用
Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea
The First Affiliated Hospital with Nanjing Medical University1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2025年10月29日最近更新:
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 1
研究概览
简要总结
A Real-World Study of Crisugabalin(HSK16149) for the Treatment of Rosacea
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 60 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosis of rosacea according to the criteria established by the ROSacea COnsensus (ROSCO) 2019 guidelines.
- •Presence of obvious facial erythema accompanied by significant burning and tingling sensations, with subjective symptoms (e.g., burning and tingling) being more severe than the observable clinical signs.
- •Refractory facial erythema despite conventional treatment, including antibiotics (metronidazole, doxycycline, and minocycline), oral isotretinoin, and oral beta-blockers.
排除标准
- •Facial inflammatory dermatoses such as acne, contact dermatitis, seborrheic dermatitis, or other facial skin diseases.
- •Pregnancy or lactation.
- •Hepatic or renal insufficiency.
- •Ongoing treatment with long-term topical glucocorticoids or retinoids.
研究组 & 干预措施
Crisugabalin(HSK16149) 20mg qd po for rosacea
Experimental
干预措施: Crisugabalin(HSK16149) 20mg qd (Drug)
Crisugabalin（HSK16149） 20mg bid po for rosacea
Experimental
Crisugabalin（HSK16149） 20mg bid po for rosacea
干预措施: Crisugabalin(HSK16149)20mg BID (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
4 期
克利加巴林治疗玫瑰痤疮的探索性临床研究玫瑰痤疮ChiCTR2600121050北京康盟慈善基金会27
已完成
2 期
Clinical study to evaluate the effect of a unani formulation of tila in melasmaCTRI/2024/02/062478Central Council for Research in Unani Medicine New Delhi48
招募中
2 期
A multicenter study to evaluate microneedling with a skin serum for treating rosacea over 20 weeks.CTRI/2025/12/098395Equipmed USA LLC55
尚未招募
不适用
A study comparing the effect of Thiamidol cream and triple combination therapy in reducing pigmentation among Melasma patientsCTRI/2025/12/098427Dr Bandreddy Peranti68
尚未招募
2/3 期
Effect Of Ghaza Husne Afza With Triple Compound Cream in MelasmaCTRI/2025/02/081453National Institute Of Unani Medicine16